Danaher (NYSE: DHR) is acquiring Masimo (NASDAQ: MASI) for $9.9 billion in an all-cash deal that values the medical technology company at $180 per share. The transaction, announced February 17, 2026, ...

By Sabrina Valle and Gnaneshwar Rajan Feb 17 (Reuters) - Danaher, a $150 billion U.S. company that makes tools used in ...

Masimo held a 23.1% share of the US pulse oximetry systems market in 2025, as per GlobalData analysis.

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics ...

Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: ...

Masimo stock jumps as it agrees to be acquired by Danaher. The company is perhaps best known for its yearslong patent dispute ...

Masimo Corporation agreed to be acquired by Danaher for $180/share, valuing MASI at $9.9B. Click here to read my most recent ...

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...

Masimo iSpO2 pulse oximeter and the iSpO2 app. Manufactured and submitted by Masimo Corp. (Irvine, CA). The iSpO2 is a measure-through-motion and low-perfusion pulse oximeter made for iPhone and iPad.